Loading...
Home2021-09-20T16:51:13+00:00

THROUGH UNIVERSITY RESEARCH AND DEVELOPMENT

With a scientific team at Western University, CanaQuest Medical Corp has created a few CREATIVE patentable product formulations. Our research and product development focuses on health products utilizing cannabis isolates and botanical compounds, including algae oils (pharmaceutical grade).

To learn more about our value proposition and the benefits of our commercial-ready products, view the full presentation on the Investors page or by clicking the thumbnail graphic further down.


Click picture above to see full-sized image.

CanaQuest Store

Visit our online store to pre-register or subscribe for information.

Online Store

Investor Presentation

Our corporate introduction document provides a comprehensive summary of CanaQuest today and its many opportunities for the future.

Click picture above to see the full presentation.

Product Formulations

PRODUCT FORMULATIONS

A critical mass of clinical evidence regarding the efficacy of medical cannabis is refuting political, scientific, and other skeptics, and opening minds hardened by decades of anti-cannabis propaganda. Our goal is to develop better alternative treatments to traditional pharmaceuticals for people struggling with a variety of health challenges.

CQ1 (Mentabinol®)

Commercial Ready
(THC + formula)

Supports mental health: Anxiety, depression, and schizophrenia.

CQ2 (Mentanine®)

Commercial Ready
(Omega 3 + formula)

Supports mental health: Anxiety, depression, PTSD and addiction.

CQ3 (Mentanine – pain®)

Commercial Ready
(Omega 3 + formula)

To support endocannabinoid system health: Inflammation and pain.

CQ4 (Menata…®)

Coming soon
(More details to be released)

To support mental health: Alzheimer’s.

Product Portfolio

FOCUS AREAS

Anxiety

Addiction

Depression

Schizophrenia

PTSD

Chronic Pain

Vision

OUR VISION

Our vision is to be a global leader in the formulation and development of health products from cannabis derivatives.

Company Information

IN THE NEWS

View All News
804, 2021

CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications

April 8th, 2021|

TORONTO, ON / April 7, 2021 -- CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman [...]